Surgical Resection of Rare Esophageal Cancers

Slides:



Advertisements
Similar presentations
Heart Transplant vs Left Ventricular Assist Device in Heart Transplant-Eligible Patients Matthew L. Williams, MD, Jaimin R. Trivedi, MD, MPH, Kelly C.
Advertisements

Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E
Elizabeth A. David, MD, David T
Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L
Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease  Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.
History of Multiple Previous Malignancies Should Not Be a Contraindication to the Surgical Resection of Lung Cancer  Pierre-Benoit Pagès, MD, Pierre Mordant,
Masatsugu Hamaji, MD, Stephen D. Cassivi, MD, K
Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F
Andrew C. Chang, MD, Andrzej S. Kosinski, PhD, Daniel P
Missed Intrapulmonary Lymph Node Metastasis and Survival After Resection of Non- Small Cell Lung Cancer  Matthew P. Smeltzer, PhD, Nicholas Faris, MDiv,
Zhiqiang Xue, MD, Fengying Wu, MD, Karlyn E
Trevor Williams, MD, MPH, Brian C
Christopher W. Seder, MD, Mark S. Allen, MD, Francis C
Salvage Resections for Recurrent or Persistent Cancer of the Proximal Esophagus After Chemoradiotherapy  Colin Schieman, MD, Dennis A. Wigle, MD, PhD,
Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J
Cooperative Group Clinical Trials in General Thoracic Surgery: Report From the 2012 Robert Ginsberg Clinical Trials Meeting of the General Thoracic Surgical.
Super-Charged Pedicled Jejunal Interposition Performance Compares Favorably With a Gastric Conduit After Esophagectomy  Elizabeth H. Stephens, MD, PhD,
Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases
Esophageal Resection for Cancer of the Esophagus: Long-Term Function and Quality of Life  Allison J McLarty, MD, Claude Deschamps, MD, Victor F Trastek,
Long Esophageal Segment Laceration Caused by an Orogastric Tube During Laparoscopic Sleeve Gastrectomy  Sang Kuon Lee, MD, Jongho Lee, MD  The Annals.
Esophagectomy Outcomes in the Endoscopic Mucosal Resection Era
Jong Ho Cho, MD, Masatsugu Hamaji, MD, Mark S. Allen, MD, Stephen D
Complex Esophageal Reconstruction Procedures Have Acceptable Outcomes Compared With Routine Esophagectomy  Jessica M. Moore, BS, Craig M. Hooker, PhD,
K. Robert Shen, MD, Mark S. Allen, MD, Stephen D
A Randomized Controlled Trial of Bupivacaine Through Intracostal Catheters for Pain Management After Thoracotomy  Mark S. Allen, MD, Lisa Halgren, RN,
Surgical treatment of metachronous second primary lung cancer after complete resection of non–small cell lung cancer  Masatsugu Hamaji, MD, Mark S. Allen,
Brendon M. Stiles, MD, Farooq Mirza, MD, Jeffrey L. Port, MD, Paul C
Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H
Philip W. Smith, MD, Hongkun Wang, PhD, Leo M. Gazoni, MD, K
Elizabeth H. Stephens, MD, PhD, Arlene M. Correa, PhD, Min P
Surgical Resection of a Giant Coronary Aneurysm
Community-Based Multidisciplinary Computed Tomography Screening Program Improves Lung Cancer Survival  Daniel L. Miller, MD, William R. Mayfield, MD,
Trevor Williams, MD, MPH, Brian C
Theolyn N. Price, MD, Mark S. Allen, MD, Francis C
Origins of the Cardiothoracic Surgery Network (CTSNet)
Surgical Considerations for the Management and Resection of Esophageal Gastrointestinal Stromal Tumors  Matthew G. Blum, MD, Karl Y. Bilimoria, MD, Jeffrey.
Quality Measures in Clinical Stage I Non-Small Cell Lung Cancer: Improved Performance Is Associated With Improved Survival  Pamela Samson, MD, MPHS, Traves.
Treatment of Postsurgical Chylothorax
Use of Amiodarone After Major Lung Resection
Karen M. Harrison–Phipps, MD, Francis C. Nichols, MD, Cathy D
John Agzarian, MD, MPH, Sue L. Visscher, PhD, Ariel W
Postpneumonectomy Empyema: Results After the Clagett Procedure
Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer  Lisa M. Brown, MD, Brian.
Robert R. McMillan, MD, MPH, Camelia S. Sima, MD, MS, Nicole H
Survival After Surgical Resection of Stage IV Esophageal Cancer
Variation in Hospital Adoption Rates of Video-Assisted Thoracoscopic Lobectomy for Lung Cancer and the Effect on Outcomes  Zaid M. Abdelsattar, MD, MS,
Felix G. Fernandez, MD, Onkar Khullar, MD, Seth D
Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer  Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,
Matthew J. Bott, MD, Hanghang Wang, BA, William Travis, MD, Gregory J
Basel Ramlawi, MD, Monika J. Leja, MD, Walid K
Hybrid Management of a Giant Left Main Coronary Artery Aneurysm
Embolized Methyl Methacrylate to the Right Atrium After Kyphoplasty
Phillip G. Rowse, MD, Dawn E
Editorial Board, January 2010
William M. Whited, MD, Paul Henley, BS, Erin M
Anirudh Vinnakota, MS, Robert Stewart, MD, Gosta Pettersson, MD, PhD 
Single Versus Double Lung Retransplantation Does Not Affect Survival Based on Previous Transplant Type  Erin M. Schumer, MD, MPH, Jonathan D. Rice, MD,
Zaid M. Abdelsattar, MD, MS, K
Specialty Training and Mortality After Esophageal Cancer Resection
Adhering to Quality Measures in Esophagectomy Is Associated With Improved Survival in All Stages of Esophageal Cancer  Pamela Samson, MD, MPHS, Varun.
Does Timing of Surgical Procedure After Neoadjuvant Chemoradiation Affect Outcomes in Esophageal Cancer?  Williams Tessier, MD, Caroline Gronnier, MD,
Shared Decision Making and Effective Risk Communication in the High-Risk Patient With Operable Stage I Non-Small Cell Lung Cancer  Pamela Samson, MD,
Bullectomy for Symptomatic or Complicated Giant Lung Bullae
Robert Lee Replogle, September 30, 1931–May 9, 2016
The American Board of Thoracic Surgery: Update
Lobectomy Versus Limited Resection in T1N0 Lung Cancer
The Impact of New Technology on Cardiothoracic Surgical Practice
Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD 
Predictors of Major Morbidity or Mortality After Resection for Esophageal Cancer: A Society of Thoracic Surgeons General Thoracic Surgery Database Risk.
Induction Chemoradiation Is Not Superior to Induction Chemotherapy Alone in Stage IIIA Lung Cancer  Asad A. Shah, MD, Mark F. Berry, MD, Ching Tzao, MD,
Presentation transcript:

Surgical Resection of Rare Esophageal Cancers Sahar A. Saddoughi, MD, PhD, Jim Taswell, PA-C, William S. Harmsen, MS, Matthew L. Inra, MD, Shanda H. Blackmon, MD, MPH, Francis C. Nichols, MD, Stephen D. Cassivi, MD, Dennis A. Wigle, MD, PhD, K. Robert Shen, MD, Mark S. Allen, MD  The Annals of Thoracic Surgery  Volume 101, Issue 1, Pages 311-315 (January 2016) DOI: 10.1016/j.athoracsur.2015.06.015 Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Overall survival from date of operation to date of death. Six of the patients are currently alive, and 1 patient was lost to follow-up. Median survival is 3.2 years. The Annals of Thoracic Surgery 2016 101, 311-315DOI: (10.1016/j.athoracsur.2015.06.015) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions